Cite
HARVARD Citation
Hauser, S. et al. (n.d.). FV 47 Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis. Clinical neurophysiology. 130 (8), pp. e142-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hauser, S. et al. (n.d.). FV 47 Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis. Clinical neurophysiology. 130 (8), pp. e142-. [Online].